| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 03/20/2008 | WO2007133983A3 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/20/2008 | US20080071084 Method for preparing alkyl ethers and aryl ethers |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070915 Poly(ADP-ribose)polymerase (PARP); ischemia, reperfusion injuries, neurological disorders, neuroprotectants, sensitizer for chemotherapy or radiotherapy, anticancer |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080070894 Anticancer agents; PLK1 inhibitors; PLK=polo-like kinase; imidazo(1,2-a)pyridines such as 5-bromo-4-[8-(difluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-1-phenylethyl]-2-pyrimidinamine |
| 03/20/2008 | US20080070888 Spirocyclic azetidin(one); 2-(3-chloro-4-fluorophenyl)-7-[5-fluoro-6-(trifluoromethyl)-1H-benzimidazol-2-yl]-3-(2-pyridinyl)-2,7-diazaspiro[3.5]nonan-1-one; T-type calcium channel blockers |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080069817 Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
| 03/20/2008 | DE102006041382A1 Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren Carbamoyl-sulphoximides as protein kinase inhibitors |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663161A1 Quinazolinone and isoquinolinone acetamide derivatives |
| 03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 03/20/2008 | CA2662937A1 Multi-functional small molecules as anti-proliferative agents |
| 03/20/2008 | CA2662617A1 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 03/20/2008 | CA2662587A1 Quinazoline based egfr inhibitors |
| 03/20/2008 | CA2661938A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 03/19/2008 | EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 03/19/2008 | EP1899307A1 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 03/19/2008 | EP1899306A2 Chloro-substituted guanidines |
| 03/19/2008 | EP1898917A1 Aminopyrimidines as kinase modulators |
| 03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1097144B1 Method for producing 4,6-disubstituted 2-isocyanatopyrimidines and their use as intermediate products for active ingredient syntheses |
| 03/19/2008 | CN101146789A Chemical compounds |
| 03/19/2008 | CN101146786A Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/19/2008 | CN101146779A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/19/2008 | CN101143864A Novel triazolo pyrimidine compounds |
| 03/19/2008 | CN101143850A Synthesizing method for thymine |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7345049 Phenylalanine derivatives |
| 03/18/2008 | US7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | CA2359089C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions et dyeing methods |
| 03/18/2008 | CA2332853C Dry powder dispersing apparatus and methods for their use |
| 03/18/2008 | CA2288705C Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 03/18/2008 | CA2225206C Aminophenyl ketone derivatives and a method for the preparation thereof |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2008030266A2 Insecticidal n-substituted (heteroaryl)alkyl sulfilmines |
| 03/13/2008 | WO2008029199A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 03/13/2008 | WO2007113558A8 Quinazolinone derivatives having b-raf inhibitory activity |
| 03/13/2008 | US20080064872 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
| 03/13/2008 | US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors |
| 03/13/2008 | US20080064696 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | CA2662850A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
| 03/13/2008 | CA2660757A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
| 03/12/2008 | EP1896475A2 Process for the preparation of bicyclic compounds |
| 03/12/2008 | EP1896436A2 Histone deacetylase inhibitors |
| 03/12/2008 | EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 03/12/2008 | EP1708713B1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 03/12/2008 | EP1663993B1 Guanidine derivatives |
| 03/12/2008 | EP1613596B1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/12/2008 | EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 03/12/2008 | EP1440063B1 Process for the preparation of 1-(pyrimidin-2-yl)propan-2-ones |
| 03/12/2008 | CN101142195A Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of C N S disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates |
| 03/12/2008 | CN100374516C Printing process using specified azo compounds |
| 03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | US7341607 Yellow anionic disazo dyes |
| 03/11/2008 | CA2310664C Substituted 2-aminoacetamides and the use thereof |
| 03/11/2008 | CA2237297C Process for the preparation of (1s,4r)-or(1r,4s)-4-(2-amino-6-chloro-9h-purin-9-yl)-2-cyclopentene-1-methanol |
| 03/06/2008 | WO2008025556A1 Sulphoximides as protein kinase inhibitors |
| 03/06/2008 | WO2007146225A3 Heterocyclic aspartyl protease inhibitors |
| 03/06/2008 | WO2007145835A3 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 03/06/2008 | WO2007131201A3 Compounds and compositions as hedgehog pathway modulators |
| 03/06/2008 | WO2007117607A9 Quinazolines for pdk1 inhibition |
| 03/06/2008 | US20080058521 Processes for the preparation of compounds |
| 03/06/2008 | US20080058520 Preparation of Aminopyrimidine Compounds |
| 03/06/2008 | US20080058358 Anticancer/antitumor agents; S-(4-([4-([(1R,2R)-2-Hydroxy-1-methylpropyl]amino)-5-(trifluoromethyl)-pyrimidin-2-yl]amino)phenyl)-S-methyl-N-[(trifluoromethyl)sulphonyl]-sulphimide for example |
| 03/06/2008 | US20080058355 Anticancer agents |
| 03/06/2008 | US20080058348 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058332 Antiproliferative, antitumor agents; 4-(3-hydroxyphenyl)-6-morpholino-2-(3-piperidin-4-ylcarbonylaminophenyl)pyrimidine for example |
| 03/06/2008 | US20080058327 4-piperazinyl-5H-6,7-dihydrocyclopenta(d)pyrimidines; Hyperproliferative diseases such as cancer |
| 03/06/2008 | US20080058319 Fused ring heterocycles as potassium channel modulators |
| 03/06/2008 | US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss |
| 03/06/2008 | US20080056990 Anilinoquinazolinyl amide derivatives; radiolabels as bioprobes for Positron Emission Tomography and Single Photon Emission Computed Tomography, and as radiopharmaceuticals for radiotherapy; improved solubility, bioavailability, biostability |
| 03/06/2008 | CA2661842A1 Serine-threonine protein kinase and parp modulators |
| 03/06/2008 | CA2661288A1 Carbamoylsulphoximides as protein kinase inhibitors |
| 03/05/2008 | EP1893600A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 03/05/2008 | EP1893587A1 Method for producing dihydroquinazolines |
| 03/05/2008 | EP1893586A1 Method for production of 1-alkyl-3-phenyluracils |
| 03/05/2008 | EP1893585A1 Process for the preparation of n-[4-(4-fluorophenyl)-5-formyl-6-isopropyl-pyrimidin-2-yl]-n-methylmethanesulfonamide |
| 03/05/2008 | EP1893584A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors |
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | EP1893212A2 Multicyclic compounds and methods of their use |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | CN101137652A Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 03/05/2008 | CN101137414A 多环双酰胺mmp抑制剂 Polycyclic bisamides mmp inhibitors |
| 03/05/2008 | CN101137381A Use of 2-anilino-3,4-dihydro-quinazolines as 5HT5a receptor antagonists |
| 03/05/2008 | CN101137380A Quinazolinone t-type calcium channel antagonists |
| 03/05/2008 | CN101137290A Use of 4-aminopyrimidines for the prevention of fungal pests novel 4-aminopyrimidines method for production thereof and agents comprising the same |